In addition, we selected four genes (FASN, GALK1, MECR, and MYC) for constructing risk model for further immunohistochemistry verification (https://www.proteinatlas.org/search/), and the results showed that there were differences in gene expression between tumor and normal tissues (Supplementary Figure 6). This evidence concerns the gene MECR and neoplasm.